Medicine

Perioperative immunotherapy for bladder cancer cells

.ANALYSIS EMPHASIZE.16 October 2024.

In the NIAGARA litigation, the enhancement of perioperative durvalumab to standard therapy for muscle-invasive sac cancer enhanced event-free as well as on the whole survival, noting a brand new treatment possibility for this health condition.

Articles You Can Be Interested In